The U.S. FDA granted marketing authorization for ProSense in October 2025 for use in low-risk early-stage breast cancer, specifically for women aged 70 and over or those unsuitable for surgery. Market ...
David Duchovny pulls the curtain back on all the government secrets in modern history we always suspected, but were never ...
An effort to temporarily halt and regulate a controversial South Alabama solar farm is raising concerns that legislation moving through Montgomery could inadvertently slow the expansion of clean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results